
semaglutide
Semaglutide in one shot a week, with a needle you never see. FDA approved for weight loss, and to lower the risk of heart attack and stroke in adults with heart disease and obesity or overweight.
From
$199/mo
without insurance
14.9%
Average loss
Plus Curie's $30 monthly service fee.
Get my Wegovy® penYour provider confirms the right medication and dose during your checkup.
14.9%
On average, people on the 2.4 mg dose of the Wegovy® pen lost 14.9% of their body weight in 68 weeks.
STEP-1 Trial, New England Journal of Medicine, 2021
Slide to your current weight.
Select your current weight
245
Your new weight
208
The average on the 2.4 mg dose in STEP 1. Your results may differ.
Once a week.
The same day each week, at any time of day, with or without food.
Press the pen to your skin and hold it there until the yellow bar in the window stops moving.
Each pen is used once, then thrown away. The needle stays hidden the whole time.
Your dose rises as your body adjusts.
Compare the lineup.
In studies in rodents, Wegovy and medicines like it caused thyroid tumors, including thyroid cancer. It is not known if Wegovy causes these tumors in people. Do not use Wegovy if you or a family member has had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider about a lump or swelling in your neck, trouble swallowing, hoarseness or shortness of breath. Serious side effects can include inflammation of the pancreas, severe stomach problems, gallbladder problems, low blood sugar with other diabetes medicines, kidney problems from dehydration, serious allergic reactions, vision changes in people with type 2 diabetes, a faster heart rate, depression or thoughts of suicide, and food or liquid getting into the lungs during surgery or sedation. Tell your provider if you are pregnant, plan to become pregnant, or are breastfeeding.